Metraipolis › archive › dc_02f91fab3d13
The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder… — Europe PMC PMID:32203532
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/32203532
- DOI
- 10.1371/journal.pone.0230417
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T04:13:30.558Z
- SHA-256 of the archived text
1c964556a86dab31f4e6679f2d1e5a83ac276b70a65df717e2d6cb6e02fc2573- Stable URL of this page
https://metraipolis.com/documento/dc_02f91fab3d13
How to cite
The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder… — Europe PMC PMID:32203532 — Europe PMC (en), https://europepmc.org/article/MED/32203532 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_02f91fab3d13 (Metraipolis archive dc_02f91fab3d13, sha256 1c964556a86dab31f4e6679f2d1e5a83ac276b70a65df717e2d6cb6e02fc2573)
BibTeX
@misc{dc02f91fab3d13,
title = {The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder… — Europe PMC PMID:32203532},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/32203532},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_02f91fab3d13; sha256 1c964556a86dab31f4e6679f2d1e5a83ac276b70a65df717e2d6cb6e02fc2573},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32203532. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Purpose: To assess the association of low- vs. guideline-recommended high-intensity cystoscopic surveillance with outcomes among patients with high-risk non-muscle invasive bladder cancer (NMIBC). Materials & methods: A retrospective cohort study of Veterans Affairs patients diagnosed with high-risk NMIBC between 2005 and 2011 with follow-up through 2014. Patients were categorized by number of surveillance cystoscopies over two years following diagnosis: low- (1-5) vs. high-intensity (6 or more) surveillance. Propensity score adjusted regression models were used to assess the association of low-intensity cystoscopic surveillance with frequency of transurethral resections, and risk of progression to invasive disease and bladder cancer death. Results: Among 1,542 patients, 520 (33.7%) underwent low-intensity cystoscopic surveillance. Patients undergoing low-intensity surveillance had fewer transurethral resections (37 vs. 99 per 100 person-years; p<0.001). Risk of death from bladder cancer did not differ significantly by low (cumulative incidence [CIn] 8.4% [95% CI 6.5-10.9) at 5 years) vs. high-intensity surveillance (CIn 9.1% [95% CI 7.4-11.2) at 5 years, p = 0.61). Low vs. high-intensity surveillance was not associated with increased risk of bladder cancer death among patients with Ta (CIn 5.7% vs. 8.2% at 5 years p = 0.24) or T1 disease at diagnosis (CIn 10.2% vs. 9.1% at 5 years, p = 0.58). Among patients with Ta disease, low-intensity surveillance was associated with decreased risk of progression to invasive disease (T1 or T2) or bladder cancer death (CIn 19.3% vs. 31.3% at 5 years, p = 0.002). Conclusions: Patients with high-risk NMIBC undergoing low- vs. high-intensity cystoscopic surveillance underwent fewer transurethral resections, but did not experience an increased risk of progression or bladder cancer death. These findings provide a strong rationale for a clinical trial to determine whether low-intensity surveillance is comparable to high-intensity surveillance for cancer control in high-risk NMIBC. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-03-23). Identificativi: PMID 32203532 · PMCID PMC7089561 · DOI 10.1371/journal.pone.0230417. Pagina: https://europepmc.org/article/MED/32203532 — https://doi.org/10.1371/journal.pone.0230417. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T04:10:07.798Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.